NHC files 8-K: Sept. 30, 2025 earnings press release attached

National HealthCare Corporation (NHC) furnished an 8-K to announce it issued a press release covering its earnings for the period ended September 30, 2025.

Accepted by SEC EDGAR 11/07/2025 - 09:18 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

National HealthCare Corporation (NHC) furnished an 8-K to announce it issued a press release covering its earnings for the period ended September 30, 2025. The full press release is provided as Exhibit 99.1, with the cover page Inline XBRL embedded as Exhibit 104. NHC’s common stock trades on the NYSE American under the symbol NHC.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NHC (NHC) file?

An 8-K announcing it issued a press release regarding its September 30, 2025 earnings.

Where can I find NHC’s earnings details?

The complete information is in Exhibit 99.1, the press release attached to the 8-K.

What exhibits are included with this 8-K?

The filing includes Exhibit 99.1 (press release) and Exhibit 104 (Cover Page Inline XBRL).

Which exchange lists NHC’s common stock?

NHC’s common stock trades on the NYSE American under the symbol NHC.

What period do the earnings relate to?

The press release covers earnings for the period ended September 30, 2025.

Which 8-K item covers the earnings announcement?

Item 2.02 (Results of Operations and Financial Condition).

Who signed the report for NHC?

The report was signed by Brian F. Kidd on behalf of National HealthCare Corporation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

false 0001047335 0001047335 2025-11-07 2025-11-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 7, 2025 (November 7, 2025)

NATIONAL HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation)	001-13489 (Commission File Number)	52-2057472 (I.R.S. Employer Identification No.)
100 E. Vine Street Murfreesboro, Tennessee (Address of Principal Executive Offices)		37130 (Zip Code)

Registrant’s telephone number, including area code: (615) 890-2020

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value	NHC	NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 2.02.         RESULTS OF OPERATIONS AND FINANCIAL CONDITION

National HealthCare Corporation (“NHC”) issued a press release on November 7, 2025, announcing its September 30, 2025 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.

ITEM 9.01.         FINANCIAL STATEMENTS AND EXHIBITS.

(d)         Exhibits.

Exhibit No.	Description of Exhibit
99.1	Copy of press release issued on November 7, 2025 by National HealthCare Corporation announcing September 30, 2025 earnings.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:         November 7, 2025

	NATIONAL HEALTHCARE CORPORATION
	By:	/s/	Brian F. Kidd

Name: Title: Brian F. Kidd Senior VP/Chief Financial Officer